Multifarious Ga-68 Labeled PET Radiopharmaceuticals in Imaging Various Malignancies

Area of Science:

• Nuclear medicine
• Radiopharmaceutical chemistry
• Molecular imaging

Background:

• Gallium-68 (Ga-68) radiopharmaceuticals are crucial for in vivo molecular imaging.
• They enable identification and characterization of tumor attributes.
• The range of Ga-68 agents includes those targeting somatostatin receptors and other specific tumor receptors.

Purpose of the Study:

• To present a variety of frequently and infrequently used gallium-labeled radiopharmaceuticals.
• To highlight their application in imaging diverse malignancies.
• To discuss their role beyond conventional imaging tracers.

Main Methods:

• Review of existing literature and clinical applications of Ga-68 radiopharmaceuticals.
• Categorization of agents based on targeting mechanisms and applications.
• Discussion of the versatility of gallium chemistry in radiolabeling.

Main Results:

• Gallium-68 demonstrates broad applicability in labeling various compounds, from nanoparticles to macromolecules.
• A spectrum of Ga-68 agents exists for specific receptor-based tumor imaging and therapeutic monitoring.
• The versatility of gallium chemistry enhances imaging specificity in clinical practice.

Conclusions:

• Gallium-labeled radiopharmaceuticals provide a versatile platform for molecular imaging of tumors.
• Ga-68 agents offer expanded options for diagnosing and monitoring various cancers.
• Further exploration of novel Ga-68 tracers can improve personalized cancer management.